CHICAGO--(BUSINESS WIRE)--Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a ...
Traditional risk assessment for cardiovascular disease (CVD) uses several factors to compile scores to formulate an estimated CVD risk, used by clinicians to advise their patients. Coronary artery ...